As part of our commitment to the highest standards of evidence, Cochrane is strengthening how it identifies and manages retracted publications associated with studies included in published or ongoing Cochrane reviews. This includes new steps to manage retractions of included studies that occur after reviews have been published.

We are looking for a new author team to update a key review on over-the-counter medicines for acute cough. The Cochrane review incorporates evidence from 1966 up to 2012 and a new search for recently published evidence is necessary. Take a look at the requirements, the support we can offer and information on how to register your interest.

Cochrane has always aimed to provide the right evidence at the right time. As we move into a more collaborative and AI-enabled era, delivering this goal will increasingly rely on structured data. Gert van Valkenhoef, Cochrane’s Head of Data, sets out why we are improving Cochrane’s approach to data, the difference this could make, and what this means for our authors.

Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.

Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.

Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.

Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.

Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.

We seek nominations for one upcoming vacant position on the Cochrane Methods Executive, to start in September 2026. Please note the deadline for nominations is Friday, 29 May 2026.

Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo

A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.

The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.

Cochrane is launching a new eight-part series of Cochrane Learning Live webinars designed to help systematic reviewers understand and apply the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) framework in evaluating the certainty of evidence in their systematic reviews.

Cochrane has confirmed the two artificial intelligence (AI) tools selected to take part in our innovative platform study evaluating how artificial intelligence could support and enhance key stages of evidence synthesis.

Cochrane has launched an innovative study to test whether artificial intelligence tools can support or enhance evidence synthesis. We only have scope to evaluate two, and so a selection process was required. Here, we outline that process and demonstrate what Cochrane values when deciding whether to use an AI tool for evidence synthesis.

Over the past 10 years Cochrane Taiwan has built a reputation for mobilizing knowledge and promoting evidence-based medicine both in Taiwan and beyond. Here they share some of the successes and learnings that have stood out over the past decade.

We’re pleased to announce four recent improvements to RevMan that will help users to structure analyses more accurately, avoid common Summary of Findings (SoF) issues, and prepare complete synthesis PICOs.

We are delighted to announce the launch of the new Cochrane Thematic Group in Infectious Diseases.

As International Women’s Day is marked around the world, women in leadership roles across the evidence and health sectors are reflecting on their careers, lessons learned and what it means to ‘give’ as a leader.